A new approach to gene editing, referred to as "soft" CRISPR, may offer a more accurate and safer method for treating genetic defects. This technique is being explored for its potential to correct various genetic disorders, including collagen and blood disorders. The effectiveness and safety of "soft" CRISPR have been demonstrated in at least one instance of a personalized gene-editing treatment, with some outlets suggesting it could potentially cure more diseases.